3D Systems warned investors of sagging sales, but said its healthcare business remains strong.
3D Systems tumbles as much as 17% after providing less-than-stellar third-quarter and full-year guidance.
Citing execution issues, 3D Systems issued a warning about its upcoming third-quarter earnings and lowered its full-year guidance.
Putting 3D Systems through the wringer to see if it currently holds the potential to become a blue chip stock.
With over $570 million in cash on its balance sheet, what is management thinking?
Approaching a short-term sell-off from a long-term perspective.
With shares off more than 55% year to date, does it pay to be contrarian?
Understanding the factors that could send shares higher over the long term.
Understanding what could derail the long-term investment thesis for 3D Systems.
Should you bet against a long-term-focused company in a high-growth industry?